| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.008 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.34 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |